http://ift.tt/eA8V8J
Não, mas exigiu mudanças da proteção de dados para o mundo multi-cloud
May 17, 2017 at 12:57AM
from
Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA) Please click the li...
http://ift.tt/eA8V8J
Não, mas exigiu mudanças da proteção de dados para o mundo multi-cloud
May 17, 2017 at 12:57AM
from
BW Businessworld |
JWT South Asia Appoints Raji Ramaswamy As CEO Of Contract Advertising
BW Businessworld Commenting on the new appointment, Tarun Rai, CEO, JWT South Asia said, “Over the last four years Rana has built an excellent team of professionals, helped in developing new capabilities, built business and reputation. As a result of his efforts … |
May 14, 2017 at 12:38AM
from
Investors typically don’t like uncertainty, and those buying shares of biotech exchange traded funds especially don’t.
A week ago the House passed a health-care bill meant to repeal and replace the Affordable Care Act. There is a long way to go before it becomes the law of the land. The bill has now landed with the Senate and will likely change a great deal in the months to come.
For the most part, health-care stocks have sloughed off the news. But one corner of the health-care market that hasn’t are biotech ETFs. In the wake of the House’s passage, First Trust NYSE Arca Biotechnology Index Fund has shed nearly 3% since las Thursday’s close, iShares Nasdaq Biotechnology ETF is off 2.4%, SPDR S&P Biotech ETF is down 2.76% and VanEck Vectors Biotech ETF is off 3.6%, according to FactSet.
By comparison, pharmaceutical and broad health-care ETFs are down only slightly during the past week. Health Care Select Sector SPDR Fund, for example, is off 0.9% over the same period, while iShares U.S. Healthcare ETF and Vanguard Health Care ETF have shed 1% and 0.9%, respectively, according to FactSet.
The broader health-care ETFs have likely sold off less because the health-care plan has far to go before anything is certain in terms of policy, and because they invest in companies that are generally less volatile than some of the smaller biotech companies.
Shares of biotechnology ETFs had done very well this year. Many of the ETFs have gained 10% or more this year through Wednesday, according to Morningstar Inc. But as policy uncertainty has increased around biotech, the rally has begun to pullback.In March, President Donald Trump tweeted that “a new system” would mean competition and lower pricing in the drug industry.
There good reason why investors are selling biotech ETFs. The group are higher-risk stocks that tend to rally more with any good news and fall further with any news that’s perceived to be negative, says Neena Mishra, director of ETF research at Zacks Investment Research.
Those ETFs with greater exposure to the more volatile and smaller-cap biotech stocks, including First Trust NYSE Arca Biotechnology Index Fund and SPDR S&P Biotech ETF, have been harder hit in the past week than those that focused more on large-cap companies, notes Todd Rosenbluth, director of ETF and mutual-fund research at financial data and analysis provider CFRA.
Some investors may be asking whether a lot of disruption in the insurance marketplace and the movement of significant numbers of individuals to insurance plans with limited benefits and higher deductibles and co-pays may have an acute effect on some higher-cost drugs, says Geoffrey Porges, a senior biotech analyst at Leerink Partners.
“I think there’s a certain amount of concern about that on the part of investors,” says Mr. Porges, though he adds that there’s nothing in the health-care plan that he’s aware of that says the impact will be felt there.
Earnings from biotechnology companies also have been a mixed bag of late, with some missing on revenue expectations, putting their shares under pressure, says Ms. Mishra. In addition, drug pricing remains a concern, and there’s some regulatory risk there, she says.
This latest weakness in the shares is likely to reverse itself, says Mr. Porges. We’re in a growth cycle with rising rates and falling unemployment, which tend to be an environment in which at least the growth end of biopharma stocks look pretty attractive, he says.
Health-care spending is rising a lot in emerging markets and there’s an increasing need for medication globally as the population ages, Ms. Mishra says. Investors should remember that biotech is a high-growth, high-risk sector, which is to the broader health-care sector what semiconductors are to the technology sector, she says.
“Both have higher growth prospects, but investors should be prepared for higher volatility as well,” she says
May 12, 2017 at 12:55AM
from Daisy Maxey
Brexit & Beyond: Europe in Flux is The Wall Street Journal’s round-up of news and analysis of how Brexit will affect global business, economies and finance. You can sign up here.
MUST READS
Bank of England Bets on Smooth Brexit: The Bank of England forecast steady if unspectacular growth for the U.K. in the years ahead—provided the country’s exit from the European Union goes smoothly.
How Emmanuel Macron’s Vision of the EU Could Further Marginalize Britain: The French president-elect’s impact on U.K. lies less in his Brexit negotiating stance than in the prospect of a more cohesive bloc, writes Simon Nixon.
U.K. Home Sales Dip Ahead of General Election: Estate agents reported a drop in home sales in April, in part due to a decline in new instructions, changes to stamp duty and uncertainty over the general election, according to a survey on Thursday.
EU Now Sees No U.K. Slowdown in 2017: The European Commission on Thursday raised its U.K. growth forecasts for the second time in six months, saying it doesn’t now expect a slowdown this year in response to the country’s June 2016 decision to leave the European Union.
EU Raises Growth Forecasts but Warns on Threat From Brexit and Trump: Europe’s economy is strengthening, the European Union said Thursday, raising this year’s growth forecast, despite geopolitical risks that could undermine its fifth year of recovery.
ECB’s Constâncio Says Time for Regulatory Light to Shine on Shadow Banking: Financial rules designed to make the financial system safer need to encompass nontraditional banks, European Central Bank Vice President Vítor Constâncio said on Thursday.
European Stocks Should Break on Through to the Other Side: Peak Europe? The Stoxx Europe 600 index is close to a level where previous ascents have repeatedly stalled. But earnings and global growth could help Europe keep climbing, writes Richard Barley.
Uber Faces Threat of Stricter Regulation in Europe After Latest Legal Setback: Uber Technologies Inc. on Thursday suffered the latest blow in its legal battles in Europe after a court adviser to the European Union’s highest court said the U.S. ride-hailing company should be regulated as a transportation company, not an online platform.
IN THE PAPERS
Tories Target Blair Country – Politico
Ireland Woos Michel Barnier as Brexit Talks Loom – Financial Times
The Brexit Trap That’s Closing on Britons Living in Europe – The Guardian
Britain’s General Election Dominated by Brexit Tactical Campaigns – NBC
Labour Manifesto Leak Reveals Re-Nationalization Plan – Politico
– Compiled with the help of Toby Luckhurst
For breaking news and intelligence on Brexit, finance, markets, deals and people from London, download WSJ City for iPhone or Android smartphone. And you can find more analysis of politics, economics and regulation in the European Union over on Real Time Brussels.
May 12, 2017 at 12:55AM
from Stephen Fidler
http://ift.tt/eA8V8J
Sinclair Broadcasting is on the verge of a deal to acquire Tribune Media, creating a local television behemoth, sources said Sunday.
May 08, 2017 at 12:55AM
from
A daily roundup of corruption news from across the Web. We also provide a daily roundup of important risk & compliance stories via our daily newsletter, The Morning Risk Report, which readers can sign up for here. Follow us on Twitter at @WSJRisk.
Bribery:
The SFO’s anti-bribery head is leaving for private practice. (GIR)
South Sudan’s interior minister warned police against taking bribes. (Sudan Tribune)
Brazil’s recent mega-events have been torn down by bribery and corruption allegations. (Guardian)
Cybercrime:
Israel indicted a hacker linked to the threats on U.S. Jewish centers. While Israel didn’t name him, a separate U.S. indictment did; his U.S. lawyer said the hacker has a mental condition. (AP, BBC)
Russia hacked the Danish defense ministry and gained access to employees’ emails, the country’s defense minister said. The Kremlin didn’t respond. (Reuters)
Australia and China struck a deal to fight cybercrime. (AAP)
Researchers say thousands of computers are infected with NSA hacking tools. (CyberScoop)
The inside story of the takedown of Silk Road is in a new book. (NY Daily News)
Money Laundering:
Filipino authorities filed a resolution planning charges Facebook account was briefly suspended. (Reuters, NY Times)
Ukraine detained two officials as it investigates a uranium corruption case. (OCCRP)
A new anti-corruption legal framework in Cyprus could allow a president to face charges. (Cyprus Mail)
An anti-corruption tour took off in Spain. (DW)
April 26, 2017 at 12:56AM
from Samuel Rubenfeld
http://ift.tt/eA8V8J
Below is a collection of my tips and feedback from a creative logo live-hacking workshop I led during the most recent 500 Startups seed accelerator program, Batch 20. The goal was to help startups better communicate their branding messages through simple yet effective design practices. Here are 7 Design Hacks we implemented to give Batch 20 companies a logo facelift: 1. Use Color Contrasts to Increase Legibility Obie.AI — A Slackbot for accessing team data. Comments: Choose a better color combination for the logo to make it easier on the eyes, especially when used as the app icon. You can use Adobe Kuler (free) to create or check your color schemes. The suggestion is: Since the product is a Slackbot, …
April 26, 2017 at 12:50AM
from Yiying Lu
http://ift.tt/17iBlr7
Why pay hundreds of thousands to earn an MBA when $100 a year will finance your blog? (Reality check: You’ll still need to put in a lot of effort.)
April 24, 2017 at 11:41PM
from Jeff Rose
Going Concern |
Consider a Mid-Market Accounting Firm Before Taking a Job in Industry
Going Concern “Two years here [a Big 4 firm] to get that on my resume, then on to private industry.” That, in a nutshell, is how lots of Big 4 associates talk about their career. For some of them, it’s a fine plan. In a way, it’s an extension of what many accounting … |
April 25, 2017 at 12:52AM
from
http://ift.tt/eA8V8J
… perspective on the full cycle of entrepreneurship; my ongoing involvement at Stitch is keeping me close to the early-stage startup community in Philly …
April 24, 2017 at 11:29PM
from
Usually when you get free advice, it’s worth about what you pay for it. Today is an exception. Here are the six most valuable components of a credit union lending program you need to align to make more consumer loans at a lower cost:
I intentionally listed “people” first. Nothing can substitute for a confident, expert lender capable of conducting a quality loan interview. Conversation is paramount, not filling in the application blanks. A solid interview reveals important information to help structure a loan properly and often unearths additional member needs. Also, you build trust and can boost member satisfaction.
The post Six keys to making more loans at a lower cost appeared first on CUInsight.
April 25, 2017 at 12:50AM
from Felix Gomez
Reason (blog) |
You Won’t Read a Full Accounting of America’s Use of Waterboarding and Torture Anytime Soon
Reason (blog) Waterboarding Ingo Wagner/EPA/NewscomA push to force the federal government to publicly release the full contents of a Senate report on the secret torture and detention of terror suspects ended quietly this morning with a simple rebuff by the Supreme … |
April 25, 2017 at 12:52AM
from